Genetics and Genomics of Lung Diseases

A special issue of Genes (ISSN 2073-4425). This special issue belongs to the section "Human Genomics and Genetic Diseases".

Deadline for manuscript submissions: closed (10 December 2025) | Viewed by 2195

Special Issue Editor


E-Mail Website
Guest Editor
Department of Internal Medicine, Division of Endocrinology, University of Texas Medical Branch, Galveston, TX 77555-1060, USA
Interests: the molecular mechanisms underlying chronic pulmonary diseases; airway remodeling/fibrosis and antiviral responses

Special Issue Information

Dear Colleagues,

Lung diseases represent a major cause of morbidity and mortality worldwide, underlining the need to unravel their genetic and genomic underpinnings to improve their diagnosis and treatment. Some lung disorders are driven by rare high-impact mutations (e.g., the monogenic defect in cystic fibrosis), whereas others, such as asthma, chronic obstructive pulmonary disease (COPD), and idiopathic pulmonary fibrosis (IPF), involve the complex contribution of numerous common genetic variants—often identified through genome-wide association studies (GWAS) and exome sequencing—together with environmental risk factors. Rapid advances in high-throughput sequencing, single-cell and spatial transcriptomics, and other genomic technologies are shedding light on the molecular pathways driving lung disease pathogenesis and revealing novel targets for therapy.

This Special Issue welcomes high-quality, cutting-edge research on GWAS and rare-variant analyses, single-cell and spatial transcriptomic profiling, epigenetic regulation, gene–environment interactions, functional genomics, and integrative multi-omics approaches. We especially welcome studies that deepen our understanding of the genetic architecture of lung diseases and translate these findings into precision medicine strategies. By assembling such contributions, our goal is to highlight the molecular mechanisms underlying lung diseases such as asthma, COPD, IPF, cystic fibrosis, and lung cancer, ultimately paving the way for improved personalized diagnostics and therapies.

Dr. Jun Yang
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Genes is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • lung diseases 
  • transcriptomics 
  • epigenetics 
  • gene–environment interaction 
  • functional genomics 
  • multi-omics integration

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

26 pages, 1797 KB  
Review
Reprogramming Fibrosis: How Protein PTMs Reshape the IPF Proteome
by Yunze Li, Wei Kong, Hanqi Zhang, Xinfeng Wei, Junxuan Yi, Mingwei Wang, Shunzi Jin and Duo Yu
Genes 2025, 16(11), 1392; https://doi.org/10.3390/genes16111392 - 20 Nov 2025
Viewed by 1836
Abstract
Idiopathic pulmonary fibrosis (IPF) is a fatal and progressive lung disorder. Its pathological process involves persistent epithelial damage, ongoing inflammation, and dysregulated tissue repair. Currently, there are no effective treatment methods to improve patient survival. However, post-translational modifications (PTMs) have gradually garnered widespread [...] Read more.
Idiopathic pulmonary fibrosis (IPF) is a fatal and progressive lung disorder. Its pathological process involves persistent epithelial damage, ongoing inflammation, and dysregulated tissue repair. Currently, there are no effective treatment methods to improve patient survival. However, post-translational modifications (PTMs) have gradually garnered widespread attention. They are the processes by which various chemical groups are added to or removed from proteins’ amino acid side chains or the N- or C-terminal ends of the polypeptide chain following synthesis. Additionally, they can regulate the energy supply of cells, regulate the cell cycle, and affect important signaling pathways such as TGF-β. This review systematically summarizes different categories of PTMs, organizes the PTMs involved in various injury stages of IPF, outlines the roles of different cells throughout the process, and analyzes future clinical diagnosis and treatment strategies as well as intervention targets for IPF, providing guiding significance for the systematic intervention of IPF in the future. Full article
(This article belongs to the Special Issue Genetics and Genomics of Lung Diseases)
Show Figures

Graphical abstract

Back to TopTop